These lung cancer facts are sending us a message
Here’s what to know about this common form of cancer and how to help people who are living with it
Nov. 19, 2026
November is Lung Cancer Awareness month, a time to learn not only what this disease is, but how we can help more people access high-quality treatment for it. Here are three top questions most people have about lung cancer.
How many people are diagnosed with lung cancer?
As many as 2.5 million people are diagnosed with lung cancer each year, according to the World Health Organization.1 That makes it one of the most common cancers in the world. Treatment varies depending on the type and stage of cancer as well as one’s medical history, but prevention, early detection and effective treatment are critically important because the disease is the leading cause of cancer-related deaths worldwide.1
What are the two main types of lung cancer?
1. Non-small cell lung cancer
- The more common of the two main types (approximately 80% to 85% of cases)
- Includes several subtypes, such as adenocarcinoma, squamous cell carcinoma and large cell carcinoma
2. Small cell lung cancer
- A less common but often more aggressive type of lung cancer
- Includes small cell carcinoma and combined small cell carcinoma2
Do you only get lung cancer from smoking?
No. This is a common misconception. Smoking is a risk factor for developing lung cancer, but it’s not the only one. Others include your family history and genetics, occupational exposure (such as diesel exhaust) and outdoor or household air pollution.1
What the facts are telling us about access to treatment
Given lung cancer’s global impact, there is a clear need to make better care available to more people around the world — and this is part of Abbott’s relentless focus. Advances in science continue to expand treatment options for patients, but not everyone has the same opportunity to benefit from them.
Awareness matters, but so does access. It’s important that we work to eliminate the barriers to early diagnosis and treatments that can make a life-changing difference. Abbott is working on expanding access to innovative cancer treatments, such as biologics and biosimilars, for multiple forms of cancer in addition to lung cancer.
“There can be multiple risk factors that can lead to the development of lung cancer,” says Dr. Mauricio Morales-Castillo, an expert in Abbott’s medicines business. “Diagnosing tumors earlier can help improve outcomes. And in emerging countries, we’re helping increase access to life-changing treatments for the most common cancers, including lung cancer.”
Understanding lung cancer is the first step in the larger journey to help the millions of people living with it. But innovation can only make a difference when it reaches the people who need it most.
References
1 https://www.who.int/news-room/fact-sheets/detail/lung-cancer
2 https://www.hopkinsmedicine.org/health/conditions-and-diseases/lung-cancer/lung-cancer-types
Related articles
For the latest on Abbott’s life-changing technology, get updates directly in your inbox.